Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris

Thrombosis Research

Volumn 117, Issue 4, 2006, Pages 371-377

  Yang, Alexander ^a   Pizzulli, Luciano ^a   Lüderitz, Berndt ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Angioplasty; Platelet activity; Platelet count; Platelet volume; Restenosis

Indexed keywords

FIBRINOGEN;

AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARAMETER; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; STABLE ANGINA PECTORIS; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; CELL SIZE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES;

EID: 32044460348     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.04.004     Document Type: Article

References (53)

1. A.R. Grüntzig, A. Senning, and W.E. Siegenthaler Non-operative dilatation of coronary artery stenosis: percutaneous transluminal angioplasty N Engl J Med 301 1979 61 68
2. A.R. Grüntzig, B.K. Spencer III, M. Schlumpf, and W. Siegenthaler Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience N Engl J Med 316 1987 1127 1132
3. D.R. Holmes Jr., R.E. Vlietstra, H.C. Smith, G.W. Vetrovec, K.M. Kent, and M.J. Cowley Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute Am J Cardiol 53 1984 77 81C
4. P.P. Leimgruber, G.S. Roubin, J. Hollman, G.A. Cotsonis, B. Meier, and J.S. Douglas Jr. Restenosis after successful coronary angioplasty in patients with single-vessel disease Circulation 73 1986 710 717
5. M. Nobuyoshi, T. Kimura, H. Nosaka, S. Mioka, K. Ueno, and H. Yokoi Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients J Am Coll Cardiol 12 1988 616 623
6. J.H. O'Keefe, B.D. Rutherford, D.R. McConahay, W.L. Johnson Jr., L.V. Giorgi, and R.W. Ligon Multivessel coronary angioplasty from 1980 to 1989: procedural results and long-term outcome J Am Coll Cardiol 16 1990 1097 1102
7. P.W. Serruys, H.E. Luijten, K.J. Beatt, R. Geuskens, P.J. De Feyter, and M. Van den Brand Incidence of restenosis after successful coronary angioplasty: a time-related phenomen. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months Circulation 77 1988 361 371
8. P. Den Heijer, R.B. van Dijk, H.L. Hillege, M.L. Pentinga, P.W. Serruys, and K.I. Lie Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty: a preamble to a multicenter trial addressing angioscopic markers for restenosis Am Heart J 128 1994 656 663
9. G.A.A. Ferns, E.W. Raines, K.H. Sprugel, A.S. Motani, M.A. Reidy, and R. Ross Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF Science 253 1991 1129 1132
10. C. Haudenschild Pathobiology of restenosis after angioplasty Am J Med 94 1993 40 44
11. J.H. Ip, V. Fuster, D. Israel, L. Badimon, J. Badimon, and J.H. Chesebro The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty J Am Coll Cardiol 17 1991 77 88B
12. M.W. Liu, G.S. Roubin, and S.B. King III Restenosis after coronary angioplasty. Potential biologic determinants and role intimal hyperplasia Circulation 79 1989 1374 1387
13. I.D. Goldberg, and M.B. Stemerman Vascular permeation of platelet factor 4 after endothelial injury Science 209 1980 611 612
14. V.M. Haver, and A.R. Gear Functional fractionation of platelets J Lab Clin Med 97 1981 187 204
15. J.F. Martin, T. Shaw, J. Heggie, and D.G. Penington Measurement of the density of human platelets and its relationship to volume Br J Haematol 54 1983 337 352
16. J.A. Jakubowski, C.B. Thompson, R. Vaillancourt, C.R. Valeri, and D. Deykin Arachidonic acid metabolism by platelets of different size Br J Haematol 53 1983 503 511
17. J.F. Martin, E.A. Trowbridge, G. Salmon, and J. Plum The biological significance of platelet volume: its relation to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration Thromb Res 32 1983 443 460
18. C.B. Thompson, K.A. Eaton, S.M. Princiotta, C.A. Ruskin, and C.R. Valeri Size dependent platelet subpopulation relationships of platelet volume to ultrastructure, enzymatic activity and function Br J Haematol 50 1982 509 519
19. C.B. Thompson, J.A. Jakubowski, P.G. Quinn, D. Deykin, and C.R. Valeri Platelet size as a determinant of platelet function J Lab Clin Med 101 1983 205 213
20. H. Giles, R.E. Smith, and J.F. Martin Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction Eur J Clin Invest 24 1994 69 72
21. D. Tschoepe, P. Roesen, L. Kaufmann, S. Schauseil, B. Kehrel, and H. Ostermann Evidence for abnormal platelet glycoprotein expression in diabetes mellitus Eur J Clin Invest 20 1990 166 170
22. J.F. Martin, J. Plumb, R.S. Kilbey, and Y.T. Kishk Changes of volume and density of platelets in myocardial infarction Br Med J 287 1983 456 459
23. H.P. Schultheiβ, D. Tschoepe, J. Esser, B. Schwippert, P. Roesen, and H.K. Nieuwenhuis Large platelets continue to circulate in an activated state after myocardial infarction Eur J Clin Invest 24 1994 243 247
24. T. O'Malley, P. Langhorne, R.A. Elton, and C. Stewart Platelet size in stroke patients Stroke 26 1995 995 999
25. A.K. Rao, R.E. Goldberg, and P.N. Walsh Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume J Lab Clin Med 103 1984 82 92
26. J.F. Martin, P.M. Bath, and M.L. Burr Influence of platelet size on outcome after myocardial infarction Lancet 338 1991 1409 1411
27. S.G. Ellis, M.G. Vandormael, M.J. Cowley, G. DiSciascio, U. Deligonul, and E.J. Topol Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease Circulation 82 1990 1193 1202
28. T.J. Ryan, D.P. Faxon, R.M. Gunnar, J.W. Kennedy, S.B. King III, and F.D. Loop Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) Circulation 78 1988 486 502
29. S.G. Ellis, G.S. Roubin, S.B. King III, J.S. Douglas Jr., and W.R. Cox Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty Am J Cardiol 63 1989 30 34
30. M.S. Huber, J. Fishman Mooney, J. Madison, and M.R. Mooney Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty Am J Cardiol 68 1991 467 471
31. E. Braunwald Unstable angina. A classification Circulation 80 1989 410 414
32. L. Pizzulli, A. Yang, J.F. Martin, and B. Lüderitz Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain Eur Heart J 19 1998 80 84
33. C. Bauters, J.M. Lablanche, E.P. McFadden, F. Leroy, and M.E. Bertrand Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris Eur Heart J 14 1993 235 239
34. O. Kamp, K. Beatt, P.J. DeFeyter, M. van den Brand, H. Suryapranata, and H. Luijten Short- and medium- and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris Am Heart J 117 1989 991 996
35. H.J. Rupprecht, R. Brennecke, M. Kottmeyer, G. Bernhard, R. Erbel, and T. Pop Short and long-term outcome after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina Eur Heart J 11 1990 964 973
36. A.M. Gladwin, M.J. Carrier, J.E. Beesley, R. Lelchuk, and J.F. Martin Identification of mRNA for PDGF B-chain in human megakaryocytes isolated using a novel immunomagnetic separation method Br J Haematol 35 1990 225 231
37. E.M. Cramer, J. Breton-Gorius, J.E. Beesley, and J.F. Martin Ultrastructural demonstration of tubular inclusions coinciding with von Willebrand factor in pig megakaryocytes Blood 71 1988 1533 1538
38. J.F. Martin, E.A. Trowbridge, G. Salmon, and D.N. Slater The relationship between platelets and megakaryocyte volumes Thromb Res 28 1982 447 459
39. F.J. De Sauvage, P.E. Hass, S.D. Spencer, B.E. Malloy, A.L. Gurney, and S.A. Spencer Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand Nature 369 1994 533 538
40. F. Wendling, E. Maraskovsky, N. Debili, C. Florindo, M. Teepe, and M. Titeux cMpl ligand is a humoral regulator of megakaryocytopoiesis Nature 369 1994 571 574
41. T. Ishibashi, and S.A. Burstein IL-3 promotes the differentiation of isolated single megakaryocytes Blood 67 1986 1512 1514
42. S. Navarro, N. Debili, J.P. Le Couedic, B. Klein, J. Breton-Gorius, and J. Doly Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication Blood 77 1991 461 471
43. M. Teramura, S. Kobayashi, S. Hoshino, K. Oshimi, and H. Mizoguchi Interleukin-11 enhances human megakaryocytopoiesis in vitro Blood 79 1992 327 331
44. P.C. Elwood, S. Renaud, D.S. Sharp, A.D. Beswick, J.R. O'Brien, and J.W. Yarnell Ischemic heart disease and platelet aggregation. The caerphilly collaborative heart disease study Circulation 83 1991 38 44
45. D.J. Fitzgerald, L. Roy, F. Catella, and G.A. Fitzgerald Platelet activation in unstable coronary disease N Engl J Med 315 1986 983 989
46. E. Thaulow, J. Erikssen, L. Sandvik, H. Stormorken, and P. Cohn Blood platelet count and function are related to total and cardiovascular death in apparently healthy men Circulation 84 1991 613 617
47. G.H. Tofler, D. Brezinski, A.I. Schafer, C.A. Czeisler, J.D. Rutherford, and S.N. Willisch Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death N Engl J Med 316 1987 1514 1518
48. M.D. Trip, V.M. Cats, F.J. Van Capelle, and J. Vreeken Platelet hyperreactivity and prognosis in survivors of myocardial infarction N Engl J Med 322 1990 1549 1554
49. G. Endler, A. Klimesch, H. Sunder-Plassmann, M. Schillinger, M. Exner, and C. Mannhalter Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease Br J Haematol 117 2002 399 404
50. A. Mathur, M.S. Robinson, J. Cotton, J.F. Martin, and J.D. Erusalimsky Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction Thromb Haemost 85 2001 989 994
51. P.K. Goel, M. Shahi, A.K. Agarwal, S. Srivastava, and P.K. Seth Platelet aggregability and occurrence of restenosis following coronary angioplasty Int J Cardiol 60 1997 227 231
52. O. Johansen, M. Brekke, I. Seljeflot, A.G. Semb, and H. Arnesen Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty Scand Cardiovasc J 38 2004 211 215
53. D.W. Smyth, J.F. Martin, L. Michalis, C.A. Bucknall, and D.E. Jewitt Influence of platelet size before coronary angioplasty on subsequent restenosis Eur J Clin Invest 23 1993 361 367